Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Open-market sale Chief Financial Officer sold 37,254 shares at an average $45.08 ($1,679,510)
  2. 4 Open-market sale Chief Financial Officer sold 20,236 shares at an average $45.02 ($910,947)
  3. 4 Open-market sale Chief Financial Officer sold 47,195 shares at $45.14 ($2,130,382)
  4. 4 Open-market sale President & CSO sold 53,729 shares at an average $37.46 ($2,012,490)
  5. 4 Option exercise President & CSO acquired 4,500 shares (option exercise)
  6. 4/A Derivatives Options or other derivatives
  7. 4 Open-market sale President & CSO sold 51,015 shares at an average $42.70 ($2,178,229)
  8. 4 Open-market sale CEO sold 50,000 shares at an average $46.33 ($2,316,428)
  9. 4 Open-market sale 10% owner sold 551 shares at $54.25 ($29,892)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale 10% owner sold 20,326 shares at an average $60.50 ($1,229,807)
  17. 4 Open-market sale CEO sold 50,000 shares at an average $65.76 ($3,288,081)
  18. 4 Open-market sale CEO sold 50,000 shares at an average $37.98 ($1,898,899)
  19. 4 Open-market sale 10% owner sold 19,466 shares at an average $50.41 ($981,205)
  20. 4 Open-market sale President & CSO sold 1,859 shares at $59.11 ($109,885)

Page 8 of 12 · 238 filings